CJC-1295 with DAC

CJC-1295 with DAC is an engineered peptide related to growth hormone-releasing hormone, developed to extend activity within the growth hormone signaling system. It has been investigated for hormonal effects, but the supplied guide does not establish clinical benefits for physique enhancement, recovery, or aging.

Growth hormone-releasing hormone participates in the regulation of growth hormone output from the pituitary gland. Growth hormone signaling also influences insulin-like growth factor 1, which contributes to growth and metabolic processes.

The proposed mechanism involves activation of the GHRH signaling pathway to increase endogenous growth hormone release. The DAC modification is intended to slow clearance and extend biological activity. Increased IGF-1 is described as a downstream hormonal response, rather than evidence of a specific therapeutic outcome.

1. 01

   Molecular target

2. 02

   Cellular signal

3. 03

   Biological process

LEVEL 03 · Early human research

Small or early-stage human studies exist, with limited certainty and reproducibility.

Evidence levels reflect the state of documented research only. They are not rankings of popularity, quality or suitability, and a higher level never implies that a compound is an approved medicine.

The source guide presents the DAC modification as a means of extending the peptide's influence on growth hormone secretion. It associates the compound with possible increases in muscle mass, improved recovery, reduced adiposity, and aging-related benefits, without providing supporting study details in the extracted material. The guide characterizes tolerability favorably while also mentioning fluid retention, flushing, and possible adverse effects associated with elevated growth hormone activity.

Source: The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 6, Introduction to Peptides (page references not verified)

Summarised in our own wording from the cited reference. The reference is a popular guide, not peer-reviewed literature; its statements are reported here as source claims rather than established facts.

Dosage, reconstitution and administration guidance is deliberately excluded from this platform.

The supplied notes do not establish whether hormonal changes translate into meaningful or durable health benefits. The strength of evidence for performance and aging-related claims, as well as long-term metabolic consequences, remains unclear.

Safety data are limited, and the guide's favorable tolerability description should not be interpreted as proof of safety. Reported or proposed concerns include flushing, fluid accumulation, joint discomfort, median nerve compression at the wrist, and reduced insulin sensitivity; the notes do not establish their frequency or causal relationship to the compound. This information is not medical advice.

Research-stage compound unless otherwise established by a competent authority. Regulatory classification differs between jurisdictions and can change over time; nothing here indicates marketing authorisation.

Primary reference for this entry:

The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 6, Introduction to Peptides (page references not verified)

Suggested literature search terms taken from the source. They are search starting points, not citations to specific studies.

• “CJC-1295 GH secretion”
• “CJC-1295 peptide clinical trial”
• “CJC-1295 with DAC for muscle growth”

Editorial status

source reviewed

Last updated

2026-09-14

Last reviewed

2026-09-13

Language

EN